DNM1L and breast carcinoma: In a series of human breast cancer samples, Zhao et al. observed a significantly increased expression of DRP1 protein in in situ ductal carcinoma in comparison with normal tissue, and in invasive breast cancer and lymph node metastases in comparison with in situ ductal carcinoma [21].